Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.

ABSTRACT:

SUBMITTER: Weber JS 

PROVIDER: S-EPMC5474305 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature